Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab vs Placebo in Hospitalized COVID-19 Patients With Respiratory Distress
NCT07196306Phase 2Withdrawn
- Sponsor
- BayCare Health System
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sarilumab in coronavirus disease 2019 (COVID-19), sponsored by BayCare Health System. Planned start May 2020; status: withdrawn.
02
Drugs
sarilumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07196306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07196306.